Lunesta Shortage Update: What Patients Need to Know in 2026

Many patients taking Lunesta (eszopiclone) for chronic insomnia have noticed it can be difficult to find at their usual pharmacy. If you've been searching for information on whether there's a Lunesta shortage in 2026, here is the most up-to-date information available.

Current Shortage Status (2026)

As of 2026, Lunesta (eszopiclone) is not on the FDA's official drug shortage list. The FDA maintains a public database of drug shortages at ashp.org and at the FDA's website, and eszopiclone does not currently appear on either. Multiple generic manufacturers supply the U.S. market, including Aurobindo Pharma, Dr. Reddy's Laboratories, and Camber Pharmaceuticals.

However, patients and providers across the country continue to report localized difficulty finding certain doses of eszopiclone at specific pharmacies. This is a stocking issue, not a true drug shortage — and the distinction matters for how you respond.

What Is Causing Localized Eszopiclone Availability Issues?

Even without a formal shortage, several factors contribute to the patchy availability patients experience:

Schedule IV controlled substance regulations. DEA regulations govern how pharmacies order, store, and dispense Schedule IV drugs like eszopiclone. Pharmacies must keep detailed records and have ordering limits that don't exist for non-controlled medications. This creates more friction in the supply chain.

Multi-generic fragmentation. With many different generic manufacturers, pharmacies commit to specific suppliers. If your pharmacy's usual eszopiclone supplier has a temporary disruption, they may be short until their next order cycle.

High demand for insomnia treatments. Insomnia affects an estimated 30-35% of U.S. adults, and awareness of effective prescription treatments continues to grow. More prescriptions being written in a given region can temporarily outpace local pharmacy stock.

Dose-specific inventory gaps. Eszopiclone comes in 1 mg, 2 mg, and 3 mg tablets. A pharmacy may carry the 1 mg and 2 mg but not the 3 mg, or vice versa. National availability data often aggregates across doses, masking gaps for specific strengths.

Historical Context: Has Lunesta Ever Had a Formal Shortage?

Lunesta has not historically appeared on the FDA's shortage list the way some other medications have. Unlike the extended Adderall shortage (which began in 2022 and persisted into 2025) or the GLP-1 shortage that peaked in 2023-2024, eszopiclone has maintained a more stable supply chain. The availability of multiple generic manufacturers has been a key buffer against formal shortage status.

That said, patients who take the brand-name Lunesta rather than generic eszopiclone may encounter greater difficulty. Brand-name Lunesta is manufactured by a single company (Waylis Therapeutics LLC) and is stocked by far fewer pharmacies than generic eszopiclone. If you're struggling to find brand-name Lunesta specifically, ask your doctor if generic eszopiclone is appropriate — in most cases it is.

What Patients Should Do Right Now

Don't panic. Eszopiclone is not in a national shortage. Localized gaps are typically resolved within days when you expand your pharmacy search.

Check multiple pharmacies. The medication is out there — just not necessarily at your usual pharmacy. Try chain pharmacies, independent pharmacies, and grocery store pharmacies in your area.

Use medfinder. medfinder calls pharmacies near you to check stock and texts you which ones have your medication and dose available — saving you hours of phone calls.

Ask your pharmacy to order it. If your pharmacy is temporarily out, they may be able to request it from their pharmaceutical distributor and receive it within 1-2 business days.

Plan refills proactively. Because Lunesta is a Schedule IV controlled substance, you typically can't request an early refill or transfer prescriptions freely. Start looking for your next refill at least 5-7 days before you run out.

Should Patients Consider Switching Medications?

With availability issues being localized and temporary rather than a true national shortage, switching medications isn't usually necessary. However, if you routinely struggle to find eszopiclone in your area, talk to your doctor about alternatives. See our full guide: Alternatives to Lunesta If You Can't Fill Your Prescription.

The Bottom Line

Lunesta is not in a formal shortage in 2026, but localized stocking gaps at individual pharmacies are a real frustration for many patients. The best response is to check more pharmacies — and tools like medfinder make that process much faster by calling pharmacies on your behalf and texting you the results.